Peppermint
•Last Updated: September 28 2022
Peppermint (Mentha piperita) is a hydrid plant that is used for its sensory properties (aroma and taste) and the oil is used internally as a carminative and intestinal aid. It appears to be well supported for relaxing the stomach and intestines, and effectively reduces abdominal pain in IBS.
Peppermint is most often used for
Last Updated: September 28 2022
Peppermint (Mentha piperita) is a plant which is a hybrid from watermint and spearmint, used initially for culinary and food manufacturing purposes but has also been used for its supposed medicinal benefits. Peppermint has an oil component which appears to be its medicinal component, and this oil has a very large content of menthol which is seen as its bioactive ingredient. This menthol is nontoxic at the recommended dose, but is the same menthol also found in some cigarette products.
The main medicinal role of peppermint is due to its muscle relaxing properties in the stomach and intestinal tract, and internal usage of peppermint appears to be able to speed up the early phase of digestion in the stomach while reducing colonic motility. It is known as a carminative agent (thought to relief flatulence), and it has a fair bit of evidence to supports its usage in reducing abdominal pain in persons with irritable bowel syndrome (IBS). It doesn't seem to influence other symptoms of IBS too much, but the reduction of abdominal pain is quite notable.
Other possible benefits of peppermint oil include fast headache relief (which involves applying a topical solution of 10% peppermint oil to the scalp at the onset of a tension headache) and possibly a reduction in nausea when used as aromatherapy. It is safe with the recommended dosages, but overconsumption of peppermint oil supplements does have a toxic level which is feasible to reach intentionally.
Note that Peppermint is also known as:
- Menthol
- Mentha piperita
- Mentha balsamea
Peppermint should not be confused with:
- Spearmint or Watermint (the plants from which peppermint is a hybrid)
Oral supplementation of peppermint oil for the purpose of gastrointestinal health and motility involves consuming anywhere between 450-750mg of the oil daily in 2-3 divided doses, and this is around 0.1-0.2mL of the oil itself per dosage. The exact optimal dosage of peppermint is not known, and the numbers reflect a menthol content somewhere between 33-50%.
Usage of peppermint for the treatment of headaches involves having a solution of 10% peppermint oil and applying a relatively thin layer to the front of your head upon the start of a headache, with another application after 15 minutes and 30 minutes (for three applications in total).
Usage of peppermint for aromatherapy does not follow any particular dosing, and similar to other forms of aromatherapy it should be used as either an oil or in a distiller until a pleasant aroma permeates the vicinity.
Any form of peppermint oil should be effective although for persons who experience heartburn (acid reflux) and wish to supplement with peppermint oil for their intestines, then an enteric coated capsule would be useful (since the muscle relaxing effects may affect the esophagous if the capsule breaks prematurely).
What works and what doesn't?
Unlock the full potential of Examine
Latest Research
2.^Grigoleit HG, Grigoleit PPharmacology and preclinical pharmacokinetics of peppermint oilPhytomedicine.(2005 Aug)
3.^Hawthorn M, Ferrante J, Luchowski E, Rutledge A, Wei XY, Triggle DJThe actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparationsAliment Pharmacol Ther.(1988 Apr)
4.^MECHANISM BY WHICH PEPPERMINT OIL EXERTS ITS RELAXANT EFFECT ON GASTROINTESTINAL SMOOTH MUSCLE.()
5.^Gershenzon J, McConkey ME, Croteau RBRegulation of monoterpene accumulation in leaves of peppermintPlant Physiol.(2000 Jan)
8.^Sugiura T, Uchida S, Namiki NTaste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating methodChem Pharm Bull (Tokyo).(2012)
9.^Kline RM, Kline JJ, Di Palma J, Barbero GJEnteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in childrenJ Pediatr.(2001 Jan)
10.^Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study.()
11.^A pharmacokinetic comparison of two delayed-release peppermint oil preparations, Colpermin and Mintec, for treatment of the irritable bowel syndrome.()
12.^Nolen HW 3rd, Friend DRMenthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndromePharm Res.(1994 Dec)
13.^Hiki N, Kaminishi M, Hasunuma T, Nakamura M, Nomura S, Yahagi N, Tajiri H, Suzuki HA phase I study evaluating tolerability, pharmacokinetics, and preliminary efficacy of L-menthol in upper gastrointestinal endoscopyClin Pharmacol Ther.(2011 Aug)
14.^Wang LH, Wang CC, Kuo SCVehicle and enhancer effects on human skin penetration of aminophylline from cream formulations: evaluation in vivoJ Cosmet Sci.(2007 May-Jun)
16.^Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka DEffectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension typeNervenarzt.(1996 Aug)
17.^Göbel H, Schmidt G, Soyka DEffect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parametersCephalalgia.(1994 Jun)
18.^MacDougall JM, Fandrick K, Zhang X, Serafin SV, Cashman JRInhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analoguesChem Res Toxicol.(2003 Aug)
19.^Ghazi AM, Salhab AS, Arafat TA, Irshaid YMEffect of mint drink on metabolism of nicotine as measured by nicotine to cotinine ratio in urine of Jordanian smoking volunteersNicotine Tob Res.(2011 Aug)
20.^Hukkanen J, Jacob P 3rd, Benowitz NLMetabolism and disposition kinetics of nicotinePharmacol Rev.(2005 Mar)
21.^Dresser GK, Wacher V, Wong S, Wong HT, Bailey DGEvaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivoClin Pharmacol Ther.(2002 Sep)
22.^Kovar KA, Gropper B, Friess D, Ammon HPBlood levels of 1,8-cineole and locomotor activity of mice after inhalation and oral administration of rosemary oilPlanta Med.(1987 Aug)
23.^Moss M, Hewitt S, Moss L, Wesnes KModulation of cognitive performance and mood by aromas of peppermint and ylang-ylangInt J Neurosci.(2008 Jan)
25.^Heuberger E, Ilmberger JThe influence of essential oils on human vigilanceNat Prod Commun.(2010 Sep)
26.^Varney E, Buckle JEffect of inhaled essential oils on mental exhaustion and moderate burnout: a small pilot studyJ Altern Complement Med.(2013 Jan)
27.^Lane B, Cannella K, Bowen C, Copelan D, Nteff G, Barnes K, Poudevigne M, Lawson JExamination of the effectiveness of peppermint aromatherapy on nausea in women post C-sectionJ Holist Nurs.(2012 Jun)
28.^Burns EE, Blamey C, Ersser SJ, Barnetson L, Lloyd AJAn investigation into the use of aromatherapy in intrapartum midwifery practiceJ Altern Complement Med.(2000 Apr)
30.^Anderson LA, Gross JBAromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nauseaJ Perianesth Nurs.(2004 Feb)
31.^Schoenen J, Timsit-Berthier MContingent negative variation: methods and potential interest in headacheCephalalgia.(1993 Feb)
32.^Beesley A, Hardcastle J, Hardcastle PT, Taylor CJInfluence of peppermint oil on absorptive and secretory processes in rat small intestineGut.(1996 Aug)
34.^Tutuian R, Castell DOReview article: oesophageal spasm - diagnosis and managementAliment Pharmacol Ther.(2006 May 15)
35.^Dalton CB, Castell DO, Hewson EG, Wu WC, Richter JEDiffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractionsDig Dis Sci.(1991 Aug)
37.^Pimentel M, Bonorris GG, Chow EJ, Lin HCPeppermint oil improves the manometric findings in diffuse esophageal spasmJ Clin Gastroenterol.(2001 Jul)
38.^Mizuno S, Kato K, Ono Y, Yano K, Kurosaka H, Takahashi A, Abeta H, Kushiro T, Miyamoto S, Kurihara R, Hiki N, Kaminishi M, Iwasaki A, Arakawa YOral peppermint oil is a useful antispasmodic for double-contrast barium meal examinationJ Gastroenterol Hepatol.(2006 Aug)
39.^Imagawa A, Hata H, Nakatsu M, Yoshida Y, Takeuchi K, Inokuchi T, Imada T, Kohno Y, Takahara M, Matsumoto K, Miyatake H, Yagi S, Ando M, Hirohata M, Fujiki S, Takenaka RPeppermint oil solution is useful as an antispasmodic drug for esophagogastroduodenoscopy, especially for elderly patientsDig Dis Sci.(2012 Sep)
40.^Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus GroupThe Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensusAm J Gastroenterol.(2006 Aug)
41.^Patrick LGastroesophageal reflux disease (GERD): a review of conventional and alternative treatmentsAltern Med Rev.(2011 Jun)
42.^Hills JM, Aaronson PIThe mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pigGastroenterology.(1991 Jul)
43.^Inamori M, Akiyama T, Akimoto K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kubota K, Saito S, Ueno N, Nakajima AEarly effects of peppermint oil on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system)J Gastroenterol.(2007 Jul)
44.^Iida H, Inamori M, Uchiyama T, Endo H, Hosono K, Akiyama T, Sakamoto Y, Fujita K, Takahashi H, Yoneda M, Koide T, Tokoro C, Goto A, Abe Y, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima AEarly effects of oral administration of lafutidine with peppermint oil, compared with lafutidine alone, on intragastric pH valuesHepatogastroenterology.(2011 Jan-Feb)
45.^Rees WD, Evans BK, Rhodes JTreating irritable bowel syndrome with peppermint oilBr Med J.(1979 Oct 6)
46.^Hiki N, Kaminishi M, Yasuda K, Uedo N, Honjo H, Matsuhashi N, Hiratsuka T, Sekine C, Nomura S, Yahagi N, Tajiri H, Suzuki HAntiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled studyGastrointest Endosc.(2011 May)
47.^Hiki N, Kaminishi M, Tanabe S, Fujisaki J, Yoshino J, Iguchi M, Kobayashi H, Ashida K, Kawabe T, Kawano T, Nomura S, Yahagi N, Tajiri H, Suzuki HAn open-label, single-arm study assessing the efficacy and safety of L: -menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopyJ Gastroenterol.(2011 Jul)
48.^Hiki N, Kaminishi M, Yasuda K, Uedo N, Kobari M, Sakai T, Hiratsuka T, Ohno K, Honjo H, Nomura S, Yahagi N, Tajiri H, Suzuki HMulticenter phase II randomized study evaluating dose-response of antiperistaltic effect of L-menthol sprayed onto the gastric mucosa for upper gastrointestinal endoscopyDig Endosc.(2012 Mar)
49.^Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann GPhytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5Phytomedicine.(2006)
50.^von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner PSTW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind studyAm J Gastroenterol.(2007 Jun)
51.^Madisch A, Holtmann G, Mayr G, Vinson B, Hotz JTreatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trialDigestion.(2004)
52.^May B, Kuntz HD, Kieser M, Köhler SEfficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsiaArzneimittelforschung.(1996 Dec)
53.^May B, Köhler S, Schneider BEfficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsiaAliment Pharmacol Ther.(2000 Dec)
54.^Holtmann G, Haag S, Adam B, Funk P, Wieland V, Heydenreich CJEffects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsiaPhytomedicine.(2003)
55.^Micklefield GH, Greving I, May BEffects of peppermint oil and caraway oil on gastroduodenal motilityPhytother Res.(2000 Feb)
56.^Micklefield G, Jung O, Greving I, May BEffects of intraduodenal application of peppermint oil (WS(R) 1340) and caraway oil (WS(R) 1520) on gastroduodenal motility in healthy volunteersPhytother Res.(2003 Feb)
57.^Fixed peppermint oil/caraway oil combination in functional dyspepsia – efficacy unaffected by H. pylori status.()
59.^Reiter M, Brandt WRelaxant effects on tracheal and ileal smooth muscles of the guinea pigArzneimittelforschung.(1985)
60.^Giachetti D, Taddei E, Taddei IPharmacological activity of essential oils on Oddi's sphincterPlanta Med.(1988 Oct)
61.^Evans BK, Heatley RV, James KC, Luscombe DKProceedings: Further studies on the correlation between biological activity and solubility of some carminativesJ Pharm Pharmacol.(1975 Dec)
62.^Shavakhi A, Ardestani SK, Taki M, Goli M, Keshteli AHPremedication with peppermint oil capsules in colonoscopy: a double blind placebo-controlled randomized trial studyActa Gastroenterol Belg.(2012 Sep)
64.^Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.()
65.^Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SKEnteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trialJ Gastroenterol.(1997 Dec)
66.^Lech Y, Olesen KM, Hey H, Rask-Pedersen E, Vilien M, Ostergaard OTreatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placeboUgeskr Laeger.(1988 Oct 3)
67.^Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio LPeppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trialDig Liver Dis.(2007 Jun)
68.^Alam MS, Roy PK, Miah AR, Mollick SH, Khan MR, Mahmud MC, Khatun SEfficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled studyMymensingh Med J.(2013 Jan)
69.^Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh RThe effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndromeDig Dis Sci.(2010 May)
70.^Leuschner M, Leuschner U, Lazarovici D, Kurtz W, Hellstern ADissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trialGut.(1988 Apr)
71.^Cholertic activity of Thapsia chem I, II, and III in rats: Comparison with terpenoid constituents and peppermint oil.()
72.^Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş NEffect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutismPhytother Res.(2007 May)
73.^Akdogan M, Ozguner M, Kocak A, Oncu M, Cicek EEffects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in ratsUrology.(2004 Aug)
74.^Grant PSpearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trialPhytother Res.(2010 Feb)
76.^Huml SSore nipples. A new look at an old problem through the eyes of a dermatologistPract Midwife.(1999 Feb)
77.^Pugh LC, Buchko BL, Bishop BA, Cochran JF, Smith LR, Lerew DJA comparison of topical agents to relieve nipple pain and enhance breastfeedingBirth.(1996 Jun)
78.^Sayyah Melli M, Rashidi MR, Delazar A, Madarek E, Kargar Maher MH, Ghasemzadeh A, Sadaghat K, Tahmasebi ZEffect of peppermint water on prevention of nipple cracks in lactating primiparous women: a randomized controlled trialInt Breastfeed J.(2007 Apr 19)
79.^Melli MS, Rashidi MR, Nokhoodchi A, Tagavi S, Farzadi L, Sadaghat K, Tahmasebi Z, Sheshvan MKA randomized trial of peppermint gel, lanolin ointment, and placebo gel to prevent nipple crack in primiparous breastfeeding womenMed Sci Monit.(2007 Sep)
80.^Garten S, Falkner RVContinual smoking of mentholated cigarettes may mask the early warning symptoms of respiratory diseasePrev Med.(2003 Oct)
81.^Giovino GA, Sidney S, Gfroerer JC, O'Malley PM, Allen JA, Richter PA, Cummings KMEpidemiology of menthol cigarette useNicotine Tob Res.(2004 Feb)
82.^Benowitz NL, Herrera B, Jacob P 3rdMentholated cigarette smoking inhibits nicotine metabolismJ Pharmacol Exp Ther.(2004 Sep)
83.^Benowitz NL, Dains KM, Dempsey D, Havel C, Wilson M, Jacob P 3rdUrine menthol as a biomarker of mentholated cigarette smokingCancer Epidemiol Biomarkers Prev.(2010 Dec)
84.^Hurrell RF, Reddy M, Cook JDInhibition of non-haem iron absorption in man by polyphenolic-containing beveragesBr J Nutr.(1999 Apr)
86.^Thorup I, Würtzen G, Carstensen J, Olsen PShort term toxicity study in rats dosed with pulegone and mentholToxicol Lett.(1983 Dec)
Primary Use